Sector Update: Health Care Stocks Mixed Pre-Bell Friday

MT Newswires Live08-28 21:17

Healthcare stocks were mixed premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) gaining by 0.1% and the iShares Biotechnology ETF (IBB) down 0.6%.

Cytokinetics (CYTK) shares were down 4%, extending the 1.6% loss in the previous session. The company said Friday that its phase 3 clinical trial of aficamten in symptomatic non-obstructive hypertrophic cardiomyopathy met both primary endpoints.

Hutchmed's (HCM) stock was up 1% after the company said a new drug application for fanregratinib to treat liver cancer has been granted conditional approval by China's National Medical Products Administration.

Eli Lilly (LLY) stock was up 0.5% after the company said the US Food and Drug Administration approved Mounjaro to lower the risk of major adverse cardiovascular events in adults with type 2 diabetes who are at high risk for those events.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment